Considerations in the design of vaccines that induce CD8 T cell mediated immunity

Vaccine

Volumn 28, Issue 49, 2010, Pages 7716-7722

  Zaiss, D M W ^a   Boog, C J P ^a,b   van Eden, W ^a   Sijts, A J A M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS VACCINE INSTITUTE   (Netherlands)

Author keywords

Antigen presentation; CD8 T cell; Immune protection; T cell priming; Vaccine design

Indexed keywords

EPITOPE; HEPATITIS B VACCINE; INFLUENZA VACCINE; INTERLEUKIN 13; LIVE VACCINE; NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; VACCINE;

CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CYTOMEGALOVIRUS; DRUG TARGETING; HEPATITIS B; HUMAN; IMMUNE RESPONSE; INFLUENZA; LISTERIA MONOCYTOGENES; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; NONHUMAN; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; ROTAVIRUS INFECTION; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, NEUTRALIZING; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; DRUG DESIGN; IMMUNODOMINANT EPITOPES; IMMUNOLOGIC MEMORY; VACCINES;

EID: 78349311152     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.08.101     Document Type: Review

References (103)

1. Rappuoli R. Bridging the knowledge gaps in vaccine design. Nat Biotechnol 2007, 25(12):1361-1366.
2. Zinkernagel R.M., Bachmann M.F., Kundig T.M., Oehen S., Pirchet H., Hengartner H. On immunological memory. Annu Rev Immunol 1996, 14:333-367.
3. Zinkernagel R.M., Althage A. Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled. J Exp Med 1977, 145(3):644-651.
4. Hou S., Doherty P.C., Zijlstra M., Jaenisch R., Katz J.M. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J Immunol 1992, 149(4):1319-1325.
5. Harty J.T., Bevan M.J. CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J Exp Med 1992, 175(6):1531-1538.
6. Kast W.M., Offringa R., Peters P.J., Voordouw A.C., Meloen R.H., van der Eb A.J., et al. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 1989, 59(4):603-614.
7. Liu J., O'Brien K.L., Lynch D.M., Simmons N.L., La Porte A., Riggs A.M., et al. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 2009, 457(7225):87-91.
8. Winau F., Weber S., Sad S., de Diego J., Hoops S.L., Breiden B., et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 2006, 24(1):105-117.
9. Dietrich G., Griot-Wenk M., Metcalfe I.C., Lang A.B., Viret J.F. Experience with registered mucosal vaccines. Vaccine 2003, 21(7-8):678-683.
10. Doolan D.L., Hoffman S.L. The complexity of protective immunity against liver-stage malaria. J Immunol 2000, 165(3):1453-1462.
11. Hoffman S.L., Goh L.M., Luke T.C., Schneider I., Le T.P., Doolan D.L., et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002, 185(8):1155-1164.
12. Schulman J.L., Kilbourne E.D. Induction of partial specific heterotypic immunity in mice by a single infection with influenza a virus. J Bacteriol 1965, 89:170-174.
13. Bennink J., Effros R.B., Doherty P.C. Influenzal pneumonia: early appearance of cross-reactive T cells in lungs of mice primed with heterologous type A viruses. Immunology 1978, 35(3):503-509.
14. Webster R.G., Askonas B.A. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol 1980, 10(5):396-401.
15. Lin Y.L., Askonas B.A. Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J Exp Med 1981, 154(2):225-234.
16. Liang S., Mozdzanowska K., Palladino G., Gerhard W. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J Immunol 1994, 152(4):1653-1661.
17. Epstein S.L., Lo C.Y., Misplon J.A., Bennink J.R. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J Immunol 1998, 160(1):322-327.
18. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007, 356(7):685-696.
19. Fisman D.N., Savage R., Gubbay J., Achonu C., Akwar H., Farrell D.J., et al. Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 2009, 361(20):2000-2001.
20. Gras S., Kedzierski L., Valkenburg S.A., Laurie K., Liu Y.C., Denholm J.T., et al. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci USA 2010, 107(28):12599-12604.
21. Pantaleo G. HIV-1 T-cell vaccines: evaluating the next step. Lancet Infect Dis 2008, 8(2):82-83.
22. Yewdell J.W., Bennink J.R. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 1999, 17:51-88.
23. Crowe S.R., Turner S.J., Miller S.C., Roberts A.D., Rappolo R.A., Doherty P.C., et al. Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections. J Exp Med 2003, 198(3):399-410.
24. Crowe S.R., Miller S.C., Shenyo R.M., Woodland D.L. Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge. J Immunol 2005, 174(2):696-701.
25. Peters B., Sette A. Integrating epitope data into the emerging web of biomedical knowledge resources. Nat Rev Immunol 2007, 7(6):485-490.
26. Sette A., Peters B. Immune epitope mapping in the post-genomic era: lessons for vaccine development. Curr Opin Immunol 2007, 19(1):106-110.
27. Steven N.M., Leese A.M., Annels N.E., Lee S.P., Rickinson A.B. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. J Exp Med 1996, 184(5):1801-1813.
28. Hislop A.D., Annels N.E., Gudgeon N.H., Leese A.M., Rickinson A.B. Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med 2002, 195(7):893-905.
29. Callan M.F., Tan L., Annels N., Ogg G.S., Wilson J.D., O'Callaghan C.A., et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998, 187(9):1395-1402.
30. Day E.K., Carmichael A.J., ten Berge I.J., Waller E.C., Sissons J.G., Wills M.R. Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J Immunol 2007, 179(5):3203-3213.
31. Lechner F., Wong D.K., Dunbar P.R., Chapman R., Chung R.T., Dohrenwend P., et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000, 191(9):1499-1512.
32. Goulder P.J., Altfeld M.A., Rosenberg E.S., Nguyen T., Tang Y., Eldridge R.L., et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med 2001, 193(2):181-194.
33. Mueller S.N., Ahmed R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA 2009, 106(21):8623-8628.
34. Gallimore A., Glithero A., Godkin A., Tissot A.C., Pluckthun A., Elliott T., et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med 1998, 187(9):1383-1393.
35. Busch D.H., Pamer E.G. T cell affinity maturation by selective expansion during infection. J Exp Med 1999, 189(4):701-710.
36. Almeida J.R., Price D.A., Papagno L., Arkoub Z.A., Sauce D., Bornstein E., et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med 2007, 204(10):2473-2485.
37. Almeida J.R., Sauce D., Price D.A., Papagno L., Shin S.Y., Moris A., et al. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 2009, 113(25):6351-6360.
38. Jaye A., Herberts C.A., Jallow S., Atabani S., Klein M.R., Hoogerhout P., et al. Vigorous but short-term gamma interferon T-cell responses against a dominant HLA-A*02-restricted measles virus epitope in patients with measles. J Virol 2003, 77(8):5014-5016.
39. Leslie A., Kavanagh D., Honeyborne I., Pfafferott K., Edwards C., Pillay T., et al. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J Exp Med 2005, 201(6):891-902.
40. Holtappels R., Podlech J., Pahl-Seibert M.F., Julch M., Thomas D., Simon C.O., et al. Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med 2004, 199(1):131-136.
41. Mongkolsapaya J., Dejnirattisai W., Xu X.N., Vasanawathana S., Tangthawornchaikul N., Chairunsri A., et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003, 9(7):921-927.
42. Barouch D.H., O'Brien K.L., Simmons N.L., King S.L., Abbink P., Maxfield L.F., et al. Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat Med. 2010, 16(3):319-323.
43. Santra S., Liao H.X., Zhang R., Muldoon M., Watson S., Fischer W., et al. Mosaic vaccines elicit CD8(+) T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nat Med. 2010, 16(3):324-328.
44. Williams M.A., Bevan M.J. Effector and memory CTL differentiation. Annu Rev Immunol 2007, 25:171-192.
45. Nanda N.K., Sercarz E. A truncated T cell receptor repertoire reveals underlying immunogenicity of an antigenic determinant. J Exp Med 1996, 184(3):1037-1043.
46. Deol P., Zaiss D.M., Monaco J.J., Sijts A.J. Rates of processing determine the immunogenicity of immunoproteasome-generated epitopes. J Immunol 2007, 178(12):7557-7562.
47. Osterloh P., Linkemann K., Tenzer S., Rammensee H.G., Radsak M.P., Busch D.H., et al. Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses. Proc Natl Acad Sci USA 2006, 103(13):5042-5047.
48. Tenzer S., Wee E., Burgevin A., Stewart-Jones G., Friis L., Lamberth K., et al. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat Immunol 2009, 10(6):636-646.
49. van der Burg S.H., Visseren M.J., Brandt R.M., Kast W.M., Melief C.J. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J Immunol 1996, 156(9):3308-3314.
50. van Heijst J.W., Gerlach C., Swart E., Sie D., Nunes-Alves C., Kerkhoven R.M., et al. Recruitment of antigen-specific CD8+ T cells in response to infection is markedly efficient. Science 2009, 325(5945):1265-1269.
51. Zehn D., Lee S.Y., Bevan M.J. Complete but curtailed T-cell response to very low-affinity antigen. Nature 2009, 458(7235):211-214.
52. Steven N.M., Annels N.E., Kumar A., Leese A.M., Kurilla M.G., Rickinson A.B. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med 1997, 185(9):1605-1617.
53. Probst H.C., Tschannen K., Gallimore A., Martinic M., Basler M., Dumrese T., et al. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J Immunol 2003, 171(10):5415-5422.
54. Mercado R., Vijh S., Allen S.E., Kerksiek K., Pilip I.M., Pamer E.G. Early programming of T cell populations responding to bacterial infection. J Immunol 2000, 165(12):6833-6839.
55. Wong P., Pamer E.G. Feedback regulation of pathogen-specific T cell priming. Immunity 2003, 18(4):499-511.
56. Willis R.A., Kappler J.W., Marrack P.C. CD8 T cell competition for dendritic cells in vivo is an early event in activation. Proc Natl Acad Sci USA 2006, 103(32):12063-12068.
57. Wieland A., Riedl P., Reimann J., Schirmbeck R. Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen. Vaccine 2009, 28(1):114-119.
58. Arens R., Schoenberger S.P. Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev 2010, 235(1):190-205.
59. Badovinac V.P., Porter B.B., Harty J.T. Programmed contraction of CD8(+) T cells after infection. Nat Immunol 2002, 3(7):619-626.
60. Prlic M., Hernandez-Hoyos G., Bevan M.J. Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response. J Exp Med 2006, 203(9):2135-2143.
61. Busch D.H., Kerksiek K.M., Pamer E.G. Differing roles of inflammation and antigen in T cell proliferation and memory generation. J Immunol 2000, 164(8):4063-4070.
62. Buller R.M., Holmes K.L., Hugin A., Frederickson T.N., Morse H.C. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 1987, 328(6125):77-79.
63. Bennett S.R., Carbone F.R., Karamalis F., Miller J.F., Heath W.R. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 1997, 186(1):65-70.
64. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F., Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998, 393(6684):478-480.
65. Ridge J.P., Di Rosa F., Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998, 393(6684):474-478.
66. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998, 393(6684):480-483.
67. Kaech S.M., Ahmed R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2001, 2(5):415-422.
68. Chang J.T., Palanivel V.R., Kinjyo I., Schambach F., Intlekofer A.M., Banerjee A., et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 2007, 315(5819):1687-1691.
69. Pipkin M.E., Sacks J.A., Cruz-Guilloty F., Lichtenheld M.G., Bevan M.J., Rao A. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 2010, 32(1):79-90.
70. Williams M.A., Bevan M.J. Shortening the infectious period does not alter expansion of CD8 T cells but diminishes their capacity to differentiate into memory cells. J Immunol 2004, 173(11):6694-6702.
71. Ahmed R., Bevan M.J., Reiner S.L., Fearon D.T. The precursors of memory: models and controversies. Nat Rev Immunol 2009, 9(9):662-668.
72. Stemberger C., Neuenhahn M., Buchholz V.R., Busch D.H. Origin of CD8+ effector and memory T cell subsets. Cell Mol Immunol 2007, 4(6):399-405.
73. Ahlers J.D., Belyakov I.M. Memories that last forever: strategies for optimizing vaccine T-cell memory. Blood 2010, 115(9):1678-1689.
74. Hou S., Hyland L., Ryan K.W., Portner A., Doherty P.C. Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature 1994, 369(6482):652-654.
75. Murali-Krishna K., Altman J.D., Suresh M., Sourdive D.J., Zajac A.J., Miller J.D., et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998, 8(2):177-187.
76. Busch D.H., Pilip I.M., Vijh S., Pamer E.G. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998, 8(3):353-362.
77. Janssen E.M., Lemmens E.E., Wolfe T., Christen U., von Herrath M.G., Schoenberger S.P. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003, 421(6925):852-856.
78. Shedlock D.J., Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003, 300(5617):337-339.
79. Sun J.C., Bevan M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003, 300(5617):339-342.
80. Williams M.A., Tyznik A.J., Bevan M.J. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 2006, 441(7095):890-893.
81. Zaiss D.M., Sijts A.J., Mosmann T.R. Enumeration of cytotoxic CD8 T cells ex vivo during the response to Listeria monocytogenes infection. Infect Immun 2008, 76(10):4609-4614.
82. Chang J., Braciale T.J. Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med 2002, 8(1):54-60.
83. Claassen E.A., van der Kant P.A., Rychnavska Z.S., van Bleek G.M., Easton A.J., van der Most R.G. Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection. J Immunol 2005, 175(10):6597-6604.
84. Lauvau G., Vijh S., Kong P., Horng T., Kerksiek K., Serbina N., et al. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 2001, 294(5547):1735-1739.
85. Muraille E., Giannino R., Guirnalda P., Leiner I., Jung S., Pamer E.G., et al. Distinct in vivo dendritic cell activation by live versus killed Listeria monocytogenes. Eur J Immunol 2005, 35(5):1463-1471.
86. Neuenhahn M., Kerksiek K.M., Nauerth M., Suhre M.H., Schiemann M., Gebhardt F.E., et al. CD8alpha+ dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen. Immunity 2006, 25(4):619-630.
87. Ribeiro-do-Couto L.M., Boeije L.C., Kroon J.S., Hooibrink B., Breur-Vriesendorp B.S., Aarden L.A., et al. High IL-13 production by human neonatal T cells: neonate immune system regulator?. Eur J Immunol 2001, 31(11):3394-3402.
88. Kang S.J., Liang H.E., Reizis B., Locksley R.M. Regulation of hierarchical clustering and activation of innate immune cells by dendritic cells. Immunity 2008, 29(5):819-833.
89. O'Ryan M. Rotarix (RIX4414): an oral human rotavirus vaccine. Expert Rev Vaccines 2007, 6(1):11-19.
90. Kew O., Morris-Glasgow V., Landaverde M., Burns C., Shaw J., Garib Z., et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002, 296(5566):356-359.
91. Acres B., Bonnefoy J.Y. Clinical development of MVA-based therapeutic cancer vaccines. Expert Rev Vaccines 2008, 7(7):889-893.
92. Tangney M., Gahan C.G. Listeria monocytogenes as a vector for anti-cancer therapies. Curr Gene Ther 2010, 10(1):46-55.
93. Moreno M., Kramer M.G., Yim L., Chabalgoity J.A. Salmonella as live trojan horse for vaccine development and cancer gene therapy. Curr Gene Ther 2010, 10(1):56-76.
94. Barouch D.H. Rational design of gene-based vaccines. J Pathol 2006, 208(2):283-289.
95. Kenter G.G., Welters M.J., Valentijn A.R., Lowik M.J., Berends-van der Meer D.M., Vloon A.P., et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med 2009, 361(19):1838-1847.
96. Melief C.J., van der Burg S.H. Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines. Nat Rev Cancer 2008, 8(5):351-360.
97. Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998, 4(3):328-332.
98. Thurner B., Haendle I., Roder C., Dieckmann D., Keikavoussi P., Jonuleit H., et al. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 1999, 190(11):1669-1678.
99. Gong J., Chen D., Kashiwaba M., Kufe D. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 1997, 3(5):558-561.
100. Morgan R.A., Dudley M.E., Wunderlich J.R., Hughes M.S., Yang J.C., Sherry R.M., et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006, 314(5796):126-129.
101. Flatz L., Hegazy A.N., Bergthaler A., Verschoor A., Claus C., Fernandez M., et al. Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8(+) T cell immunity. Nat Med. 2010, 16(3):339-345.
102. Schwarz K., Meijerink E., Speiser D.E., Tissot A.C., Cielens I., Renhof R., et al. Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles. Eur J Immunol 2005, 35(3):816-821.
103. Bonifaz L.C., Bonnyay D.P., Charalambous A., Darguste D.I., Fujii S., Soares H., et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 2004, 199(6):815-824.